Erolcan Sayar

11PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|Dec 12, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis.

Jeanne M Dsouza, Erolcan Sayar, Michael T Schweizer

|Nov 27, 2025
Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies.

Darleen S Tu, Aaron K Olson, Kimberly S Waggie

|Aug 06, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.

Hyun Jung Lee, Roman Gulati, Erolcan Sayar

|Nov 26, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies.

Michael C Haffner, Michael J Morris, Chien-Kuang C Ding

|Jul 05, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.

Samir Zaidi, Jooyoung Park, Joseph M Chan

Pageof 2

Frequent Collaborators

9 joint publications

Michael C Haffner

5 joint publications

Peter S Nelson

4 joint publications

Eva Corey

4 joint publications

Michael T Schweizer